Shares of Bristol-Myers Squibb Co. rose on Friday, a day after a judge halted sales of a generic form of Plavix because of possible patent infringement. Canadian drugmaker Apotex Inc. began selling a cheap, generic version of the blood thinner three weeks ago, but Manhattan U.S. District Judge Sidney Stein blocked sales because of a patent dispute. The ruling was only a partial win for Bristol-Myers and its French partner Sanofi Adventis. Judge Sidney Stein refused to order a recall of any generics that have already been sold to distributors. Plavix is used by 48 million Americans and is Bristol-Meyers’ best-selling product.

Posted by GEN-ERIC at 02:25:01 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/830

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)